Home › Funds › Aristotle Capital Boston, LLC › NOVT
Aristotle Capital Boston, LLC position in NOVT
NOVANTA INC · Miscellaneous
Aristotle Capital Boston, LLC reported holding 139,009 shares of NOVT (NOVANTA INC) in its Q2 2026 13F filing — a position valued at US$22.6M, representing 1.51% of its reported portfolio and ranking #10 among its reported holdings. Aristotle Capital Boston, LLC has disclosed NOVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Aristotle Capital Boston, LLC's NOVT position evolved
Aristotle Capital Boston, LLC first disclosed a stake in NOVT in Q3 2023 at 171,156 shares (US$24.6M). The position peaked in Q3 2024 at 169,954 shares, worth US$30.4M. Across 12 filings, Aristotle Capital Boston, LLC increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 139,009 shares valued at US$22.6M — a reduction of -26,930 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 171.16K | $24.55M | New |
| Q4 2023 | 173.63K | $29.24M | Add |
| Q1 2024 | 172.56K | $30.16M | Reduce |
| Q2 2024 | 168.74K | $27.52M | Reduce |
| Q3 2024 | 169.95K | $30.41M | Add |
| Q4 2024 | 151.66K | $23.17M | Reduce |
| Q1 2025 | 129.51K | $16.56M | Reduce |
| Q2 2025 | 122.66K | $15.81M | Reduce |
| Q3 2025 | 148.88K | $14.91M | Add |
| Q4 2025 | 176.68K | $21.02M | Add |
| Q1 2026 | 165.94K | $19.62M | Reduce |
| Q2 2026 | 139.01K | $22.55M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NOVT and 13F data
NOVT (NOVANTA INC) is a Miscellaneous company. 39 other funds we track also report a position in NOVT — the largest reported positions include Daiwa Securities Group Inc. (US$347.5M), Allspring Global Investments Holdings, LLC (US$297.5M), Conestoga Capital Advisors, LLC (US$197.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NOVT
- Daiwa Securities Group Inc. 2.14M sh · $347.52M · Q2 2026
- Allspring Global Investments Holdings, LLC 1.82M sh · $297.54M · Q2 2026
- Conestoga Capital Advisors, LLC 1.22M sh · $197.60M · Q2 2026
- WASATCH ADVISORS LP 1.05M sh · $149.60M · Q3 2026
- GW&K Investment Management, LLC 897.27K sh · $145.57M · Q2 2026
- CONGRESS ASSET MANAGEMENT CO 979.84K sh · $139.32M · Q3 2026
- Baron Funds 850.49K sh · $137.98M · Q2 2026
- BAMCO INC /NY/ 850.49K sh · $137.98M · Q2 2026
- GENEVA CAPITAL MANAGEMENT LLC 758.88K sh · $123.12M · Q2 2026
- Mawer Investment Management Ltd. 589.57K sh · $95.65M · Q2 2026
- Telemark Asset Management, LLC 425.00K sh · $68.95M · Q2 2026
More on Aristotle Capital Boston, LLC
FAQ
How long has Aristotle Capital Boston, LLC held NOVT?
Aristotle Capital Boston, LLC has disclosed NOVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Aristotle Capital Boston, LLC's current position in NOVT?
As of Q2 2026, Aristotle Capital Boston, LLC holds 139.01K shares of NOVT (NOVANTA INC), valued at $22.55M, representing 1.51% of its reported portfolio and ranking #10.
Has Aristotle Capital Boston, LLC been buying or selling NOVT?
In the latest 13F filing (Q2 2026), Aristotle Capital Boston, LLC reduced its position in NOVT. The position peaked in Q3 2024 at 169.95K shares.
Which other funds hold NOVT?
Other major institutional holders of NOVT include Daiwa Securities Group Inc., Allspring Global Investments Holdings, LLC, Conestoga Capital Advisors, LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.